I was scrolling through Instagram in early August 2020 when I saw an advertisement that caught my attention. Usually, I swipe past these without a second glance, but this was for the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine trial. It was recruiting participants for the highly publicized phase 3 trial of a new vaccine, BNT162b2, that had shown promising results earlier in the year. As a nurse and researcher who has encountered social media recruitment in my own work—and has closely followed the COVID-19 vaccine trials—I was curious to see how Pfizer planned to convince 30 000 people in the US to volunteer. I clicked on the advertisement.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Corresponding Author: Kristen R. Choi, PhD, RN, School of Nursing, University of California, 700 Tiverton Ave, Room 3-238, Los Angeles, CA 90095 (firstname.lastname@example.org).
Published Online: December 7, 2020. doi:10.1001/jamainternmed.2020.7087
Conflict of Interest Disclosures: Dr Choi reported grants from the Agency for Healthcare Research and Quality outside the submitted work.
You currently have no searches saved.
You currently have no courses saved.